Here are the materials in Comingdeer v. Cherokee Nation (Cherokee Dist. Ct.):
Nation Motion to DQ Attorney Smith
Objection to Cherokee Nation s Motion to Deem Objection Confessed
Objection to Motion to Dismiss
Order Denying Motion to DQ Attorney Smith
Order Overruling Defendant s Motion to Dismiss and Ruling on Other Pending Motions
Reply in Support of Defendant s Motion to Dismiss
Final Judgment Under Advisement, Verdict Form 1, and Verdict Form 2
Download(PDF) brief in the matter of McKesson Corp. et al. v. Hembree et al., 17-cv-00323 (D. Okla.):
Links: Previous posts, Murphy v. Royal (10th Cir. Aug. 8, 2017)
Here are the materials in the matter of McKesson Corp. et al. v. Hembree et al., 17-cv-00323 (D. Okla.):
Doc. 95 – Response of Judicial Officers to Motion for Preliminary Injunction
Complaint and motion previously posted here.
Tribal court complaint previously posted here.
Here are the materials in McKesson Corp. v. Hembree (N.D. Okla.):
The tribal court complaint in Cherokee Nation of Oklahoma v. McKesson Corp. is here.
Here is the complaint in Cherokee Nation of Oklahoma v. McKesson Corp. (Cherokee Nation Dist. Ct.):
News coverage in WaPo: “Cherokee Nation sues drug firms, retailers for flooding communities with opioids.”
Here are the materials in GlaxoSmithKline LLC v. Cherokee Nation (D. Mass.):
An excerpt:
The dispute in this case centers on a 2012 settlement agreement entered into by Plaintiff GlaxoSmithKline LLC (“GlaxoSmithKline” or “GSK”) in connection with its plea in a criminal proceeding, United States of America v. GlaxoSmithKline, LLC, Criminal Action No. 12-10206-RWZ (D. Mass). GlaxoSmithKline now seeks a declaratory judgment that claims brought by the Cherokee Nation in the District Court of the Cherokee Nation were released by the settlement agreement. Presently at issue are GlaxoSmithKline’s Renewed Cross-Motion for Summary Judgment [#61] and the Cherokee Nation’s Cross-Motion for Summary Judgment [#64]. For the following reasons, GlaxoSmithKline’s motion is DENIED and the Cherokee Nation’s motion is ALLOWED.
We posted the complaint here.
Here is the complaint in GlaxoSmithKline LLC v. Cherokee Nation (D. Mass.):
An excerpt:
By filing suit in the Tribal Court for conduct relating to the marketing, sale and promotion of Avandia, the Cherokee Nation breached the Avandia Settlement Agreement in three ways. First, the Avandia Settlement Agreement clearly specifies that the exclusive jurisdiction and venue over disputes under the Avandia Settlement Agreement are vested in the United States District Court for the District of Massachusetts. Filing suit in the Tribal Court was a breach of this exclusive jurisdiction and venue provision. Second, the Cherokee Nation’s suit runs afoul of the Avandia Settlement Agreement because it asserts claims that were released under the Avandia Settlement Agreement. Third, the suit purports to seek relief under the “statutory, common, and decisional laws of the Cherokee Nation,” notwithstanding that disputes under the Settlement Agreement are “governed under the laws of the United States.”
Here are the materials in Anglen v. Cherokee Nation Council:
Turtle Talk 
You must be logged in to post a comment.